You can help expand this article with text translated from the corresponding article in Russian. (January 2022)Click [show] for important translation instructions.
|
Date | 5 December 2020 [2] – present |
---|---|
Location | Russia |
Cause | COVID-19 pandemic in Russia |
Target | Immunization against COVID-19 |
Participants | 81,580,140 people have received at least one dose (21 June 2022) [3] 74,311,072 people have been fully vaccinated (21 June 2022) [3] |
Outcome | 55.86% of the Russian population has received at least one dose of a vaccine [lower-alpha 1] [3] [4] 50.88% of the Russian population has been fully of a vaccine [lower-alpha 2] [3] [4] |
Website | Стопкоронавирус.рф |
The COVID-19 vaccination campaign in Russia is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Russia became the first country to begin a mass COVID-19 vaccination programme on 5 December 2020, [2] starting with primarily doctors, medical workers and teachers. In January 2021, this was extended to the entire population. [5] [6]
As of 21 June 2022, 81.5 million people have received at least one dose, with 79.7 million people fully vaccinated. [3] [7] [4] [8]
On 11 August 2020, President Putin said in a meeting that the Sputnik V vaccine (registered as Gam-COVID-Vac) developed by the Gamaleya Research Institute of Epidemiology and Microbiology was the first vaccine against the coronavirus to be registered. He said that one of his daughters was vaccinated. [9] The previous day, the Association of Clinical Research Organisations, a union of pharmaceutical companies in Russia, urged the head of the Ministry of Health to delay the registration due to incomplete testing. [10] The head of the Russian Direct Investment Fund (RDIF) stated that 20 countries had requested in total 1 billion doses of the vaccine, nicknamed Sputnik V. [11] On August 20 registration was called "conditional" with final registration depends on results of Phase 3 trial, [12] such registration is limited and allowed by Decree 441 for medicines in emergency situations. [13]
On 8 September 2020, the health ministry's press service said that the first batches of the vaccine developed by the Gamaleya Centre had entered civilian circulation. [14]
On 14 October 2020, President Vladimir Putin announced that the EpiVacCorona vaccine was approved. [15] Registration is limited ("on conditions") and regulated by Decree 441 for emergency use. [16] [17]
On 20 February 2021, President Vladimir Putin announced that the CoviVac vaccine was approved. [18] Registration is limited ("on conditions") too and regulated by Decree 441 for emergency situation. [16] [17]
On 6 May 2021, Sputnik Light vaccine was approved. [19]
Vaccine | Emergency Use Approval [17] | Deployment | Final Approval |
---|---|---|---|
Sputnik V | 10 August 2020 [20] | 27 November 2020 [21] | 4 February 2022 |
EpiVacCorona | 14 October 2020 [15] | 18 January 2021 [22] | No |
CoviVac | 20 February 2021 [18] | 25 March 2021 [23] | No |
Sputnik Light | 6 May 2021 [19] | Not yet | No |
This article needs to be updated.(December 2021) |
On 2 December 2020, President Putin ordered the start of mass vaccination of the population for the next week, starting with doctors, medical workers and teachers. [5] On 5 December, vaccinations began in Moscow. [24]
On 10 December 2020, Deputy Prime Minister Tatyana Golikova announced that approximately 6.9 million doses of the Sputnik V vaccine will enter civilian circulation in Russia before the end of February 2021. [25] On December 15, the Ministry of Health announced the start of mass vaccination in all regions. [26]
On 6 January 2021, the RDIF announced that 1 million people had been vaccinated with the Sputnik V vaccine. On January 10, 2021, the RDIF stated that over 1.5 million people had been vaccinated. [27]
By 17 February 2021, 2.2 million people had received the first dose of the Sputnik V vaccine and another 1.7 million people had received both doses. [28]
By 15 March 2021, over 3.5 million people had received both doses of the Sputnik V vaccine, according to the RDIF. [29]
On 9 April 2021, Prime Minister Mikhail Mishustin said that less than half of those vaccinated were over the age of 60. [30]
On 14 April 2021, Moscow Mayor Sergei Sobyanin said that around 820,000 Muscovites had been fully vaccinated, out of a population of 12 million. Sobyanin also said that Moscow was "fully supplied" with vaccines and urged Muscovites to get vaccinated. By 14 April, an estimated 9.5 million Russians had received at least one vaccine dose, with around 5.6 million having received both doses. [31]
On 25 April 2021, Sobyanin announced that those over the age of 60 who get vaccinated would be eligible to receive a gift card worth 1,000 rubles to spend in shops, raised through contributions from businesses, in an effort to incentivize the vaccination campaign. [32] [33]
On 26 April 2021, 11.9 million people overall had received at least a first dose of a vaccine, representing 10% of the adult population. [33]
On 21 May 2021, Mayor of Moscow Sobyanin decried low demand for vaccines, despite free and easy access to them since January. In a meeting, he said: "It's a shame that we have not had any restrictions on vaccinations for six months and we were the first in the world to launch a mass vaccination campaign... Unfortunately, we still have 9,000 Muscovites in hospitals with severe cases of coronavirus... People are still dying, yet don't want to get vaccinated". Sobyanin also stated that the percentage of people vaccinated in Moscow was less than in any other European city. [34] [35]
On 16 June 2021, Sobyanin announced that Moscow would introduce mandatory vaccinations for service workers in the city, following a surge in cases in the city. Business operating in service sectors would be required to have at least 60% of their workforce vaccinated with a first dose by 15 July, with both doses by 15 August. [36]
On 22 June 2021, Sobyanin announced that, beginning 28 June, restaurants, bars and cafes in Moscow would be restricted to those who can show they have been vaccinated, had the virus confirmed within the last six months, or tested negative in the last three days. [37] By 22 June, compulsory vaccinations were also decided in a number of other regions aside from Moscow and Moscow Oblast, including the city of St. Petersburg, the Sakha Republic, the Nenets Autonomous Okrug, the Leningrad, Tula, Kemerovo, Sakhalin and Tver oblasts, and Krasnodar Krai. Kremlin spokesman Dmitry Peskov also stated that discrimination against the unvaccinated was inevitable. [38]
By 2 July 2021, compulsory vaccinations were introduced in a total of 24 federal subjects, with compulsory vaccinations planned to be introduced in Crimea and Murmansk Oblast. [39]
Public scepticism of being vaccinated remains high. [31] A poll by the Levada Center released on 1 March 2021 found that 62% of Russian respondents did not want to receive the country's Sputnik V vaccine, with younger respondents being more reluctant. [40] Another poll by the Levada Center released on 12 May found that 62% of Russian respondents were not ready to get vaccinated with Sputnik V, with 75% of respondents aged 18–24 years old not ready compared to 47% for those over 55 years of age. [41] A survey by the SuperJob.ru job portal published on 16 May found that 42% of Russian respondents would not get vaccinated under any circumstances. [42] Public scepticism continues to exist despite Russian and Western sources detailing the positive efficacy of the vaccine. [43] A study in 2017 indicated that anti-vaccine views had been present in Russia prior to the pandemic, which only increased after the pandemic emerged. [44]
Kirill Alexandrovich Dmitriev is the CEO of the Russian Direct Investment Fund (RDIF), a $10 billion sovereign wealth fund created by the Russian government to co-invest in the Russian economy. His wife Natalia Popova, a deputy director of the NGO Innopraktika Foundation, works for and is a very close friend of Putin's younger daughter Katerina Tikhonova. In February 2022, both Kirill Dmitriev and RDIF were sanctioned by the United States Treasury, following the Russian invasion of Ukraine. Under Mr. Dmitriev's leadership RDIF claims to be the first state owned Russian company to call for diplomatic solution and peace in Ukraine.
The COVID-19 pandemic in Russia was a part of the pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2.
The COVID-19 pandemic in Belarus was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have spread to Belarus, when the first case of COVID-19 in the country was registered in Minsk on 28 February 2020. As of 29 January 2023, a total of 19,047,714 vaccine doses have been administered.
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).
Turkmenistan is the only remaining sovereign country in the world that has not reported any cases of COVID-19. There were no confirmed cases of COVID-19 in Turkmenistan, with the totalitarian government being proactive in censoring relevant information. It is however suspected to have spread in the country unreported; specifics are difficult to ascertain and confirm in absence of independent media.
Sputnik V or Gam-COVID-Vac is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.
India began administration of COVID-19 vaccines on 16 January 2021. As of 4 March 2023, India has administered over 2.2 billion doses overall, including first, second and precautionary (booster) doses of the currently approved vaccines. In India, 95% of the eligible population (12+) has received at least one shot, and 88% of the eligible population (12+) is fully vaccinated.
EpiVacCorona is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack of protective effectiveness of EpiVacCorona, which is still in use in Russia, has been reported in scientific literature and in the media. The vaccine consists of three chemically synthesized peptides that are conjugated to a large carrier protein. This protein is a fusion product of a viral nucleocapsid protein and a bacterial MBP protein. A phase III clinical trial to show whether or not the vaccine can protect people against COVID-19 was launched in November 2020 with more than three thousand participants. The conclusions and results of the trial have not been made public.
The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.
On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. As of 17 June 2022, 6,260,228 people have received their first dose, 4,598,703 have received their second dose, and 851,874 have received a third dose.
COVID-19 vaccination in Moldova started on 2 March 2021. During the COVID-19 pandemic, Moldova was very reliant on external help from other countries, having received donations of vaccines from Romania, the United Arab Emirates, Russia and China. In fact, Moldova's vaccination campaign started due to a donation from Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru Botizatu. Romania had promised earlier, on 29 December 2020, that it would help Moldova with a collaboration project which would include 200,000 vaccine doses to help Moldova combat the pandemic, but also other matters of the country. Romania subsequently made more donations on 27 March 2021 with 50,400 vaccine units; on 17 April 2021 with 132,000 vaccine doses, fulfilling its promise to Moldova; and on 7 May 2021 with 100,800 vaccine units even though this surpassed the promised 200,000 vaccine doses.
On 29 January 2021, Algeria launched a COVID-19 vaccination campaign, a day after receiving its first shipment of 50,000 doses of the Russia's Sputnik V vaccine. As of 6 June 2021, around 2.5 million doses have been administered. Algeria is currently vaccinating its population with both Sputnik V and Oxford-AstraZeneca vaccines.
COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.
QazCovid-in, commercially known as QazVac, is a COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan. QazCoVac-P is a second COVID-19 vaccine developed by the Kazakh Biosafety Research Institute and in clinical trials.
Sputnik Light is a single dose COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector, and it can be stored at a normal refrigerator temperature of 2–8 °C (36–46 °F). The institute says this version would be ideally suited for areas with acute outbreaks, allowing more people to be vaccinated quickly. It will also be used as a third (booster) dose for those who received Sputnik V at least 6 months earlier.
COVID-19 vaccination in Kazakhstan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.
Russia .. saying the vaccine approval was a "conditional registration certificate"
provisional approval was issued under conditions established by Government Decree 441
регистрация была выдана "на условиях", определенных постановлением правительства (No. 441)
This is a reckless and foolish decision. Mass vaccination with an improperly tested vaccine is unethical. Any problem with the Russian vaccination campaign would be disastrous both through its negative effects on health, but also because it would further set back the acceptance of vaccines in the population.